GlaxoSmithKline plc Profile

USD 0.25  0.64%

GlaxoSmithKline plc Summary

GlaxoSmithKline plc (GSK) is traded on BATS Exchange in USA. It is located in UNITED KINGDOM and employs 98,462 people. GlaxoSmithKline plc is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 94.89 B. GlaxoSmithKline plc runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 4.91 B outstanding shares of which 7.97 M shares are currently shorted by investors with about 1.96 days to cover shorted positions. GLAXOSMITHKLINE P has about 5.46 B in cash with (6.02 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22.
Check GlaxoSmithKline plc Probability Of Bankruptcy

Ownership Allocation (%)

GlaxoSmithKline plc Target Price Odds Analysis

Odds Below 39.46HorizonTargetOdds Above 39.46
59.74%30 days 39.46 40.18%
Based on normal probability distribution, the odds of GlaxoSmithKline plc to move above current price in 30 days from now is about 40.18% (This GlaxoSmithKline plc probability density function shows the probability of GlaxoSmithKline plc Stock to fall within a particular range of prices over 30 days) .

GlaxoSmithKline plc Top Holders

GlaxoSmithKline plc Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares48.2 M1.9 B
Royal Bank Of CanadaCommon Shares21 M845.1 M
View GlaxoSmithKline plc Diagnostics

GlaxoSmithKline plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

GlaxoSmithKline plc Key Fundamentals

GlaxoSmithKline plc Against Markets

GlaxoSmithKline plc Current Ratings

GlaxoSmithKline plc 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for GlaxoSmithKline plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline plc operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 98462 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
GlaxoSmithKline plc SEC Filings
GlaxoSmithKline plc SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameGlaxoSmithKline plc
CEO, Executive DirectorAndrew WittyView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
Business Address980 Great West Road
Foreign Associates
ExchangeBATS Exchange
CIK Number0001131399
IndustryDrug Manufacturers - Major
Phone44 20 8047 5000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

GlaxoSmithKline plc Directors

GlaxoSmithKline plc Corporate Directors

Vindi Banga Senior Independent Non-Executive Director
Lynn Elsenhans Independent Non-Executive Director
Daniel Podolsky Non-Executive Independent Director
Please also check Risk vs Return Analysis. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.